Thirty-two years old male patient presented with four day history of mild redness, pain and blurring of vision of the left eye. He gave history of similar episode 4-5 months back and it subsided with treatment. Visual acuity on presentation was 6/6 RE and 5/60 → 6/12 with -1.5 DSph/-2.75 D Cyl at 110º (left eye). Anterior segment was normal in the right eye. In the left eye, fine keratic precipitates on cornea and trace anterior chamber cells and flare were noted. Pigments were seen on anterior capsule of lens. Dilated fundus examination revealed a normal appearing disc with no cup in right eye and pale disc with C:D ratio 0.8 with a thin neuro-retinal rim in the left eye. Colour vision was normal. Intraocular pressure (IOP) was 14 and 35 mm Hg by applanation in the right and left eyes, respectively. On gonioscopy ciliary body band was visible for 360 degree without any peripheral anterior synechiae or inflammatory deposits. Automated perimetry revealed full visual field in the right eye and a dense scotoma with central island of field in the left eye. He was treated with oral and topical antiglaucoma medications along with topical steroids. On follow up, his vision was 6/6 (right eye) and 6/12 (left eye) with IOP of 12 and 16 mm Hg.
Introduction
Posner-Schlossman syndrome (PSS), also known as glaucomatocyclitic crisis, is a disease characterized by acute, unilateral, recurrent attacks of elevated intraocular pressure (IOP) accompanied by mild anterior chamber inflammation (1) . The inflammation may follow the rise in intraocular pressure by some days or is so mild to be overlooked, so the etiology for rise of IOP may not be clear at the initial presentation. The pathophysiology is still unknown, although there are several theories proposed ranging from autoimmune to infectious. Treatment management is focused on controlling the intraocular pressure and decreasing inflammation. While an attack usually resolves without sequelae, repeated attacks over time may lead to long-term glaucomatous damage. PSS can be a challenging diagnosis at presentation with raised IPO which is disproportionate compared to the mild symptoms and minimal signs of anterior segment inflammation. This can lead to a misdiagnosis of PACG and unnecessary laser 
Case History
A 32 years old male patient presented with complaints of mild redness, pain and blurring of vision of the left eye for last 4 days. He gave history of similar episode 4-5 months back and it subsided with some treatment. There were no associated complaints of floaters, flashes and coloured halos. Visual acuity on presentation was 6/6 unaided in the right eye and 5/60 improving to 6/12 with-1.5 DSph/-2.75 D Cyl at 110 degrees in the left eye. Right eyeanterior segment examination was within normal limits. In the left eye, there was no circumcorneal congestion present. Fine keratic precipitates were noted in the cornea ( Figure 1 ) and trace anterior chamber cells and flare were noted. Pigments were seen on anterior capsule of lens ( Figure 2 ). There was no vitritis present. Dilated fundus examination revealed a normal appearing disc with no cup in right eye and pale disc with C:D ratio 0.8 with a thin neuro retinal rim in the left eye. Colour vision was normal. IOP was 18 and 35 mm Hg by applanation in the right and left eye, respectively. On gonioscopy ciliary body band was visible for 360 degree without any peripheral anterior synechiae or inflammatory deposits ( Figure 4 ). Automated perimetry revealed full visual field in the right eye and a dense scotoma with central island of field in the left eye. For acute management of the patient's elevated IOP, acetazolamide (500 mg, t.d.s), E/D Timolol + Dorzox (eye drop, t.d.s) and E/D Brimonidine (eye drop, t.d.s) were started. The IOP decreased to 24 mm Hg after several hours. Due to the subtle anterior segment inflammation, prednisolone acetate 1% was also started. The patient was instructed to continue timolol-dorzolamide twice daily, brimonidine tartrate twice daily, and prednisolone acetate 1% four times daily. On follow up after one week, his vision was 6/6 (right eye) and 6/12 (left eye) and IOP had decreased to 16 mm Hg in the left eye. His prednisolone acetate 1% was tapered and IOP lowering medications were gradually stopped. Figure 3 : Gonioscopy revealed open angles in both eyes (ciliary body band was visible 360 degrees without any synechiae/ inflammatory deposits). 
Gonioscopic examination Open angles in both eyes
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Discussion
Posner and Schlossman first reported a series of 9 cases who suffered from recurrent unilateral attacks of ocular hypertension in individuals aged 20-50 years with duration of attack varying from few hours to several weeks (2) . These patients showed signs of a slight decrease in vision, elevated IOP with open angles, corneal edema with a few keratic precipitates, heterochromia with anisocoria, and a large pupil in the affected eye. Analysis of visual fields and optic discs was found to be normal. The exact pathophysiology of PSS is still unknown. Both immunological and infectious etiologies have been considered in the pathogenesis (3) (4) (5) . PSS is a rare condition with an uncertain aetiology and no recognised associated systemic conditions. A Japanese study of 22 patients with PSS showed that HLABw54 was positive in nine (41%), implicating a possible CD8 T-cell immunogenetic role (6). Herpes simplex virus has been detected in the anterior chamber of a small sample of three patients during ocular hypertensive attacks (7) . There are two reports of non-arteritic ischaemic optic neuropathy (NAION) associated with PSS attacks (8, 9) . Both patients had small optic discs with little or no physiological cupping in the affected eye, which are known risk factors for NAION (10) . In this case the patient is a 32 years male who presented with typical history of recurrent attacks of with asymptomatic period between the attacks. Mild anterior chamber reaction with signs of raised IOP and response to topical steroids and anti-glaucoma agents helped in clinching the diagnosis of PSS.
The diagnosis of PSS can be easily missed due to its mild inflammatory nature (11) . The diagnosis is based upon clinical features and the elimination of other possibilities which includes acute and chronic angle closure glaucoma, primary open angle glaucoma, ocular hypertension, herpetic anterior uveitis, and fuchs heterochromic iridocyclitis. Primary open angle glaucoma was ruled out as signs of inflammation are usually absent and it is a bilateral disease with raised IOP, open angles, optic disc and visual field defects. Persistently elevated IOP without resolution with lack of anterior chamber inflammation pinpoints to the diagnosis of ocular hypertension. Absence of significant PAS on gonioscopy rules out chronic angle closure glaucoma. Fuchs heterochromic iridocyclitis can be ruled out due to absence of heterochromia, stellate shaped keratic precipitates, fine abnormal angle vessels on gonioscopy and posterior subcapsular cataract.
Initial treatment is directed towards controlling intraocular pressure and decreasing inflammation. Typical first-line therapeutics include topical beta-blockers such as timolol, alphaagonists such as brimonidine, and carbonic anhydrase inhibitors such as dorzolamide. Apraclonidine has also been advocated as a first-line agent (12) . Systemic anti-glaucoma agents like hyperosmotics and carbonic anhydrase inhibitors can be used to lower the IOP in acute attacks (13) . In cases where the IOP cannot be controlled using maximal medical therapy, surgical therapy may be considered, especially when signs of glaucomatous optic nerve damage or visual field changes appear (14) .
Conclusion
PSS is a challenging problem. Early detection and diagnosis through careful clinical examination followed by appropriate ancillary testing and treatment is an effective strategy to manage it. It has long thought to be a "benign" disease; most patients are treated for attacks and recover without long-term sequelae. However, the development of glaucomatous field defects and optic neuropathy has been found to be proportional to the duration of elevated IOP and not the frequency of attacks. Therefore, patients with PSS should be followed, at minimum on an annual basis even if their attacks occur on a less frequent basis.
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